A vaginal exam reveals a client's membranes have ruptured, their cervix is dilated to 7 cm, and the fetal head is at station +1. What priority action would the nurse take in response?

Choice A rationale

Live attenuated virus vaccines (e.g., Measles, Mumps, Rubella, Varicella, Nasal-spray Flu) are generally contraindicated during pregnancy because of the theoretical risk that the attenuated virus could cross the placenta and potentially cause a fetal infection or teratogenic effects. The principle of prudence dictates avoiding live vaccines when the immune system of the mother and the developing fetus could be affected.

Choice B rationale

This instruction is dangerously incorrect, as live virus immunizations are contraindicated in pregnancy due to the risk of fetal harm (potential infection or teratogenesis). Immunizations that are recommended during pregnancy are typically inactivated (e.g., Tdap, injectable Flu) as they contain non-replicating components that cannot infect the fetus.

Choice C rationale

While inactivated virus vaccines (or toxoids) are generally considered safer because they do not contain live, replicating virus, the statement that they are always safe and can be given at any time is a false generalization. Immunization recommendations are based on risk-benefit analysis considering the stage of pregnancy, maternal risk, and potential fetal exposure, which is why specific schedules exist (e.g., Tdap usually in the third trimester).

Choice D rationale

This is incorrect; the inactivated (injectable) influenza vaccine is, in fact, highly recommended for pregnant clients at any stage to protect both the mother (who is at higher risk of severe illness) and the newborn (via passive immunity). The only immunization that should be avoided is the live attenuated influenza vaccine (nasal spray).

Choice A rationale

Contractions occurring occasionally and lasting for 30 seconds every 2 minutes still represent a persistent pattern of uterine activity. The primary goal of tocolytic therapy is to inhibit or suppress uterine contractions in preterm labor. Therefore, contractions occurring every two minutes, even if occasional and short, do not fully demonstrate the desired outcome of effectively stopping or significantly spacing out the labor process.

Choice B rationale

A Fetal Heart Rate (FHR) of 170 bpm is a concerning fetal tachycardia (normal range is 110-160 bpm). Additionally, a decrease from moderate to minimal variability indicates a reduction in the healthy push-pull of the fetal autonomic nervous system, suggesting potential fetal distress or compromise. Neither fetal tachycardia nor decreased variability is a desired outcome from tocolytic therapy, which aims to improve the fetal environment.

Choice C rationale

A FHR of 140 bpm is within the normal range, but minimal variability suggests reduced fetal reserve or a drug effect, and the presence of late decelerations is a non-reassuring sign, indicative of uteroplacental insufficiency (a drop in FHR after the peak of a contraction). These findings collectively suggest fetal compromise and are not a desired outcome after initiating a tocolytic medication intended to prolong gestation.

Choice D rationale

Contractions slowing is the direct desired therapeutic effect of tocolytic agents like magnesium sulfate or nifedipine, as it prevents preterm birth. A fetal heart rate of 130 bpm is within the normal range (110-160 bpm), and moderate variability (6 to 25 beats per minute amplitude) is the most favorable and reassuring sign of adequate fetal oxygenation and a healthy central nervous system. This combination reflects a stable maternal-fetal status. .